Cargando…
Hyperuricemia contributes to glucose intolerance of hepatic inflammatory macrophages and impairs the insulin signaling pathway via IRS2-proteasome degradation
AIM: Numerous reports have demonstrated the key importance of macrophage-elicited metabolic inflammation in insulin resistance (IR). Our previous studies confirmed that hyperuricemia or high uric acid (HUA) treatment induced an IR state in several peripheral tissues to promote the development of typ...
Autores principales: | , , , , , , , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9513153/ https://www.ncbi.nlm.nih.gov/pubmed/36177037 http://dx.doi.org/10.3389/fimmu.2022.931087 |
_version_ | 1784797993476554752 |
---|---|
author | Zhao, Hairong Lu, Jiaming He, Furong Wang, Mei Yan, Yunbo Chen, Binyang Xie, De Xu, Chenxi Wang, Qiang Liu, Weidong Yu, Wei Xi, Yuemei Yu, Linqian Yamamoto, Tetsuya Koyama, Hidenori Wang, Wei Zhang, Chenggui Cheng, Jidong |
author_facet | Zhao, Hairong Lu, Jiaming He, Furong Wang, Mei Yan, Yunbo Chen, Binyang Xie, De Xu, Chenxi Wang, Qiang Liu, Weidong Yu, Wei Xi, Yuemei Yu, Linqian Yamamoto, Tetsuya Koyama, Hidenori Wang, Wei Zhang, Chenggui Cheng, Jidong |
author_sort | Zhao, Hairong |
collection | PubMed |
description | AIM: Numerous reports have demonstrated the key importance of macrophage-elicited metabolic inflammation in insulin resistance (IR). Our previous studies confirmed that hyperuricemia or high uric acid (HUA) treatment induced an IR state in several peripheral tissues to promote the development of type 2 diabetes mellitus (T2DM). However, the effect of HUA on glucose uptake and the insulin sensitivity of macrophages and its mechanism is unclear. METHODS: To assess systemic IR, we generated hyperuricemic mice by urate oxidase knockout (UOX-KO). Then, glucose/insulin tolerance, the tissue uptake of 18F-fluorodeoxyglucose, body composition, and energy balance were assessed. Glucose uptake of circulating infiltrated macrophages in the liver was evaluated by glucose transporter type 4 (GLUT-4) staining. Insulin sensitivity and the insulin signaling pathway of macrophages were demonstrated using the 2-NBDG kit, immunoblotting, and immunofluorescence assays. The immunoprecipitation assay and LC-MS analysis were used to determine insulin receptor substrate 2 (IRS2) levels and its interacting protein enrichment under HUA conditions. RESULTS: Compared to WT mice (10 weeks old), serum uric acid levels were higher in UOX-KO mice (WT, 182.3 ± 5.091 μM versus KO, 421.9 ± 45.47 μM). Hyperuricemic mice with metabolic disorders and systemic IR showed inflammatory macrophage recruitment and increased levels of circulating proinflammatory cytokines. HUA inhibited the nuclear translocation of GLUT-4 in hepatic macrophages, restrained insulin-induced glucose uptake and glucose tolerance, and blocked insulin IRS2/PI3K/AKT signaling. Meanwhile, HUA mediated the IRS2 protein degradation pathway and activated AMPK/mTOR in macrophages. LC-MS analysis showed that ubiquitination degradation could be involved in IRS2 and its interacting proteins to contribute to IR under HUA conditions. CONCLUSION: The data suggest that HUA-induced glucose intolerance in hepatic macrophages contributed to insulin resistance and impaired the insulin signaling pathway via IRS2-proteasome degradation |
format | Online Article Text |
id | pubmed-9513153 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | Frontiers Media S.A. |
record_format | MEDLINE/PubMed |
spelling | pubmed-95131532022-09-28 Hyperuricemia contributes to glucose intolerance of hepatic inflammatory macrophages and impairs the insulin signaling pathway via IRS2-proteasome degradation Zhao, Hairong Lu, Jiaming He, Furong Wang, Mei Yan, Yunbo Chen, Binyang Xie, De Xu, Chenxi Wang, Qiang Liu, Weidong Yu, Wei Xi, Yuemei Yu, Linqian Yamamoto, Tetsuya Koyama, Hidenori Wang, Wei Zhang, Chenggui Cheng, Jidong Front Immunol Immunology AIM: Numerous reports have demonstrated the key importance of macrophage-elicited metabolic inflammation in insulin resistance (IR). Our previous studies confirmed that hyperuricemia or high uric acid (HUA) treatment induced an IR state in several peripheral tissues to promote the development of type 2 diabetes mellitus (T2DM). However, the effect of HUA on glucose uptake and the insulin sensitivity of macrophages and its mechanism is unclear. METHODS: To assess systemic IR, we generated hyperuricemic mice by urate oxidase knockout (UOX-KO). Then, glucose/insulin tolerance, the tissue uptake of 18F-fluorodeoxyglucose, body composition, and energy balance were assessed. Glucose uptake of circulating infiltrated macrophages in the liver was evaluated by glucose transporter type 4 (GLUT-4) staining. Insulin sensitivity and the insulin signaling pathway of macrophages were demonstrated using the 2-NBDG kit, immunoblotting, and immunofluorescence assays. The immunoprecipitation assay and LC-MS analysis were used to determine insulin receptor substrate 2 (IRS2) levels and its interacting protein enrichment under HUA conditions. RESULTS: Compared to WT mice (10 weeks old), serum uric acid levels were higher in UOX-KO mice (WT, 182.3 ± 5.091 μM versus KO, 421.9 ± 45.47 μM). Hyperuricemic mice with metabolic disorders and systemic IR showed inflammatory macrophage recruitment and increased levels of circulating proinflammatory cytokines. HUA inhibited the nuclear translocation of GLUT-4 in hepatic macrophages, restrained insulin-induced glucose uptake and glucose tolerance, and blocked insulin IRS2/PI3K/AKT signaling. Meanwhile, HUA mediated the IRS2 protein degradation pathway and activated AMPK/mTOR in macrophages. LC-MS analysis showed that ubiquitination degradation could be involved in IRS2 and its interacting proteins to contribute to IR under HUA conditions. CONCLUSION: The data suggest that HUA-induced glucose intolerance in hepatic macrophages contributed to insulin resistance and impaired the insulin signaling pathway via IRS2-proteasome degradation Frontiers Media S.A. 2022-09-13 /pmc/articles/PMC9513153/ /pubmed/36177037 http://dx.doi.org/10.3389/fimmu.2022.931087 Text en Copyright © 2022 Zhao, Lu, He, Wang, Yan, Chen, Xie, Xu, Wang, Liu, Yu, Xi, Yu, Yamamoto, Koyama, Wang, Zhang and Cheng https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms. |
spellingShingle | Immunology Zhao, Hairong Lu, Jiaming He, Furong Wang, Mei Yan, Yunbo Chen, Binyang Xie, De Xu, Chenxi Wang, Qiang Liu, Weidong Yu, Wei Xi, Yuemei Yu, Linqian Yamamoto, Tetsuya Koyama, Hidenori Wang, Wei Zhang, Chenggui Cheng, Jidong Hyperuricemia contributes to glucose intolerance of hepatic inflammatory macrophages and impairs the insulin signaling pathway via IRS2-proteasome degradation |
title | Hyperuricemia contributes to glucose intolerance of hepatic inflammatory macrophages and impairs the insulin signaling pathway via IRS2-proteasome degradation |
title_full | Hyperuricemia contributes to glucose intolerance of hepatic inflammatory macrophages and impairs the insulin signaling pathway via IRS2-proteasome degradation |
title_fullStr | Hyperuricemia contributes to glucose intolerance of hepatic inflammatory macrophages and impairs the insulin signaling pathway via IRS2-proteasome degradation |
title_full_unstemmed | Hyperuricemia contributes to glucose intolerance of hepatic inflammatory macrophages and impairs the insulin signaling pathway via IRS2-proteasome degradation |
title_short | Hyperuricemia contributes to glucose intolerance of hepatic inflammatory macrophages and impairs the insulin signaling pathway via IRS2-proteasome degradation |
title_sort | hyperuricemia contributes to glucose intolerance of hepatic inflammatory macrophages and impairs the insulin signaling pathway via irs2-proteasome degradation |
topic | Immunology |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9513153/ https://www.ncbi.nlm.nih.gov/pubmed/36177037 http://dx.doi.org/10.3389/fimmu.2022.931087 |
work_keys_str_mv | AT zhaohairong hyperuricemiacontributestoglucoseintoleranceofhepaticinflammatorymacrophagesandimpairstheinsulinsignalingpathwayviairs2proteasomedegradation AT lujiaming hyperuricemiacontributestoglucoseintoleranceofhepaticinflammatorymacrophagesandimpairstheinsulinsignalingpathwayviairs2proteasomedegradation AT hefurong hyperuricemiacontributestoglucoseintoleranceofhepaticinflammatorymacrophagesandimpairstheinsulinsignalingpathwayviairs2proteasomedegradation AT wangmei hyperuricemiacontributestoglucoseintoleranceofhepaticinflammatorymacrophagesandimpairstheinsulinsignalingpathwayviairs2proteasomedegradation AT yanyunbo hyperuricemiacontributestoglucoseintoleranceofhepaticinflammatorymacrophagesandimpairstheinsulinsignalingpathwayviairs2proteasomedegradation AT chenbinyang hyperuricemiacontributestoglucoseintoleranceofhepaticinflammatorymacrophagesandimpairstheinsulinsignalingpathwayviairs2proteasomedegradation AT xiede hyperuricemiacontributestoglucoseintoleranceofhepaticinflammatorymacrophagesandimpairstheinsulinsignalingpathwayviairs2proteasomedegradation AT xuchenxi hyperuricemiacontributestoglucoseintoleranceofhepaticinflammatorymacrophagesandimpairstheinsulinsignalingpathwayviairs2proteasomedegradation AT wangqiang hyperuricemiacontributestoglucoseintoleranceofhepaticinflammatorymacrophagesandimpairstheinsulinsignalingpathwayviairs2proteasomedegradation AT liuweidong hyperuricemiacontributestoglucoseintoleranceofhepaticinflammatorymacrophagesandimpairstheinsulinsignalingpathwayviairs2proteasomedegradation AT yuwei hyperuricemiacontributestoglucoseintoleranceofhepaticinflammatorymacrophagesandimpairstheinsulinsignalingpathwayviairs2proteasomedegradation AT xiyuemei hyperuricemiacontributestoglucoseintoleranceofhepaticinflammatorymacrophagesandimpairstheinsulinsignalingpathwayviairs2proteasomedegradation AT yulinqian hyperuricemiacontributestoglucoseintoleranceofhepaticinflammatorymacrophagesandimpairstheinsulinsignalingpathwayviairs2proteasomedegradation AT yamamototetsuya hyperuricemiacontributestoglucoseintoleranceofhepaticinflammatorymacrophagesandimpairstheinsulinsignalingpathwayviairs2proteasomedegradation AT koyamahidenori hyperuricemiacontributestoglucoseintoleranceofhepaticinflammatorymacrophagesandimpairstheinsulinsignalingpathwayviairs2proteasomedegradation AT wangwei hyperuricemiacontributestoglucoseintoleranceofhepaticinflammatorymacrophagesandimpairstheinsulinsignalingpathwayviairs2proteasomedegradation AT zhangchenggui hyperuricemiacontributestoglucoseintoleranceofhepaticinflammatorymacrophagesandimpairstheinsulinsignalingpathwayviairs2proteasomedegradation AT chengjidong hyperuricemiacontributestoglucoseintoleranceofhepaticinflammatorymacrophagesandimpairstheinsulinsignalingpathwayviairs2proteasomedegradation |